1. Home
  2. GXAI vs EVGN Comparison

GXAI vs EVGN Comparison

Compare GXAI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaxos.ai Inc.

GXAI

Gaxos.ai Inc.

N/A

Current Price

$0.40

Market Cap

5.4M

Sector

N/A

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.27

Market Cap

5.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GXAI
EVGN
Founded
2021
1999
Country
United States
Israel
Employees
3
N/A
Industry
Agricultural Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
5.1M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
GXAI
EVGN
Price
$0.40
$0.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 119.5K
39.2K
Earning Date
11-20-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.35
N/A
EPS
N/A
★ N/A
Revenue
★ $1,933,030.00
N/A
Revenue This Year
$462.16
N/A
Revenue Next Year
$30.00
$81.06
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 47901.74
N/A
52 Week Low
$0.41
$0.35
52 Week High
$5.26
$1.28

Technical Indicators

Market Signals
Indicator
GXAI
EVGN
Relative Strength Index (RSI) 37.21 21.66
Support Level N/A N/A
Resistance Level $0.52 $0.41
Average True Range (ATR) 0.04 0.02
MACD 0.01 -0.00
Stochastic Oscillator 27.02 7.95

Price Performance

Historical Comparison
GXAI
EVGN

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: